BioCentury | Oct 3, 2016
Financial News

Onxeo completes private placement

...EUR12.5 million ($14 million) Shares: 5.4 million Price: EUR2.30 Shares after offering: 46.9 million Investors: Financiere de la Montagne...
BioCentury | Nov 24, 2014
Financial News

Onxeo proposes rights offering

...35.4 million ($44.1 million) Shares: 7.9 million Price: ?4.50 Shares outstanding prior: 31.5 million Investors: Financiere de la Montagne...
BioCentury | Jul 28, 2014
Financial News

BioAlliance completes debt financing

BioAlliance Pharma S.A. (Euronext:BIO), Paris, France Business: Cancer, Infectious, Drug delivery Date completed: 2014-07-18 Type: Debt financing Raised: EUR10 million ($13.5 million) Investor: Financière de la Montagne Note: The loan bears 15% interest and matures...
Items per page:
1 - 3 of 3
BioCentury | Oct 3, 2016
Financial News

Onxeo completes private placement

...EUR12.5 million ($14 million) Shares: 5.4 million Price: EUR2.30 Shares after offering: 46.9 million Investors: Financiere de la Montagne...
BioCentury | Nov 24, 2014
Financial News

Onxeo proposes rights offering

...35.4 million ($44.1 million) Shares: 7.9 million Price: ?4.50 Shares outstanding prior: 31.5 million Investors: Financiere de la Montagne...
BioCentury | Jul 28, 2014
Financial News

BioAlliance completes debt financing

BioAlliance Pharma S.A. (Euronext:BIO), Paris, France Business: Cancer, Infectious, Drug delivery Date completed: 2014-07-18 Type: Debt financing Raised: EUR10 million ($13.5 million) Investor: Financière de la Montagne Note: The loan bears 15% interest and matures...
Items per page:
1 - 3 of 3